| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.008 |